Sort
35,931 grants matching “parkinsons”
Mechanisms of Manganese Neurotoxicity
$604,504Michael Aschner · Albert Einstein College Of Medicine · R01 · FY2014 · ES
Elucidating electrical stimulation induced non-neuronal activity using emerging in vivo imaging technology and electrophysiology
$604,484Takashi Daniel Yoshida Kozai · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · NS
Elucidating electrical stimulation induced non-neuronal activity using emerging in vivo imaging technology and electrophysiology
$604,484Takashi Daniel Yoshida Kozai · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · NS
Citalopram as a posterior cortical protective therapy in Parkinson disease
$604,478Vikas Kotagal · University Of Michigan At Ann Arbor · R01 · FY2023 · AG
Proteostasis dysregulation and alpha-synuclein
$604,470Xin Qi · Case Western Reserve University · R01 · FY2021 · NS
Proteostasis dysregulation and alpha-synuclein
$604,470Xin Qi · Case Western Reserve University · R01 · FY2023 · NS
Proteostasis dysregulation and alpha-synuclein
$604,470Xin Qi · Case Western Reserve University · R01 · FY2022 · NS
A Novel Approach to Assessing Cognitive State During Real-World Tasks
$604,385Chris Berka · Advanced Brain Monitoring, Inc. · R42 · FY2015 · MH
Identifying Circuit Dynamics Underlying Motor Dysfunction in ParkinsonÂs Disease Using Real-Time Neural Control
$604,251David Escobar Sanabria · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia
$604,239Sivan Subburaju · Mclean Hospital · R01 · FY2025 · MH
Diagnostic Innovations in Glaucoma Study: Visual Function
$604,129Pamela A Sample · University Of California, San Diego · R01 · FY2007 · EY
GXI Interactions
$604,090John Blangero · University Of Texas Hlth Science Center · U19 · FY2024 · AG
OpenSim Enhancements to Enable Computational Design of Personalized Treatments for Movement Impairments
$604,064Benjamin J Fregly · Rice University · R01 · FY2023 · EB
Dissection of SARM1-Induced Axon Degeneration and Cell Death
$603,990Jeffrey D Milbrandt · Washington University · R01 · FY2025 · NS
CLINICAL, GENETIC, AND CELLULAR CONSEQUENCES OF MUTATIONS IN NA,K-ATPASE ATP1A3
$603,953Allison Brashear · State University Of New York At Buffalo · R01 · FY2024 · NS
Role of reactive astrocytes in prion diseases
$603,869Ilia V Baskakov · University Of Maryland Baltimore · R01 · FY2024 · NS
Proteostasis dysregulation and alpha-synuclein
$603,869Xin Qi · Case Western Reserve University · R01 · FY2020 · NS
ENIGMA Parkinsonâs Initiative: A Global Initiative for Parkinsonâs Disease
$603,714Paul M Thompson · University Of Southern California · R01 · FY2024 · NS
Encephalitic viral infection and susceptibility to dopaminergic neurotoxins
$603,534Ronald B Tjalkens · Colorado State University · R01 · FY2021 · ES
Targeting Cerebellar Endoplasmic Reticulum Calcium Handling in Essential Tremor
$603,504Sheng-Han Kuo · Columbia University Health Sciences · R01 · FY2022 · NS
Impact of Metabotropic Glutamate Receptor Heteromerization on Signaling and Pharmacology
$603,392Jonathan A Javitch · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2025 · NS
Parkinson Disease Clinical Subtypes: Validation, Clinical Utility, and Biological Correlates
$603,341Meghan C Campbell · Washington University · R01 · FY2023 · NS
CYClical Lower Extremity exercise for Parkinsons trial (CYCLE Trial)
$603,229Jay L Alberts · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · NS
Genetic analysis in families with neurological disease
$603,199Andrew Singleton · National Institute On Aging · ZIA · FY2009 · AG
Biomimetic Surface for Neural Implants
$603,180Xinyan Tracy Cui · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · NS